Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Viking Thera (VKTX)

Viking Thera (VKTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,390,639
  • Shares Outstanding, K 112,310
  • Annual Sales, $ 0 K
  • Annual Income, $ -109,960 K
  • EBIT $ -172 M
  • EBITDA $ -189 M
  • 60-Month Beta 0.62
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 3.74

Options Overview Details

View History
  • Implied Volatility 143.81% ( +16.85%)
  • Historical Volatility 61.23%
  • IV Percentile 100%
  • IV Rank 100.00%
  • IV High 143.81% on 07/08/25
  • IV Low 60.62% on 06/03/25
  • Put/Call Vol Ratio 0.15
  • Today's Volume 31,121
  • Volume Avg (30-Day) 18,727
  • Put/Call OI Ratio 0.26
  • Today's Open Interest 219,990
  • Open Int (30-Day) 214,402

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 18 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/25
See More
  • Average Estimate -0.44
  • Number of Estimates 11
  • High Estimate -0.37
  • Low Estimate -0.54
  • Prior Year -0.20
  • Growth Rate Est. (year over year) -120.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
23.80 +26.85%
on 06/23/25
30.75 -1.82%
on 07/08/25
+2.36 (+8.48%)
since 06/06/25
3-Month
18.92 +59.57%
on 04/09/25
30.75 -1.82%
on 07/08/25
+10.21 (+51.10%)
since 04/08/25
52-Week
18.92 +59.57%
on 04/09/25
81.73 -63.06%
on 10/28/24
-20.82 (-40.82%)
since 07/08/24

Most Recent Stories

More News
Better Growth Buy: Eli Lilly vs. Viking Therapeutics

VKTX : 30.19 (+9.74%)
NVO : 69.64 (+0.46%)
LLY : 777.66 (+0.62%)
GS : 697.28 (-1.92%)
Why I Think Viking Therapeutics Is an Asymmetric Growth Opportunity

VKTX : 30.19 (+9.74%)
2 Beaten-Down Stocks With Massive Upside Potential

VKTX : 30.19 (+9.74%)
CRSP : 54.82 (+7.09%)
10 Incredible Growth Stocks Poised for Long-Term Gains

VKTX : 30.19 (+9.74%)
ACHR : 10.37 (+3.49%)
NVTS : 6.58 (+6.99%)
OSCR : 16.55 (-1.55%)
BBAI : 7.59 (-2.44%)
RKLB : 38.74 (-0.36%)
EQIX : 767.39 (-1.25%)
JOBY : 11.39 (+6.85%)
LUNR : 10.68 (+2.59%)
PLTR : 139.71 (+0.42%)
Got $200? 2 Biotech Stocks to Buy and Hold Forever

VKTX : 30.19 (+9.74%)
NVO : 69.64 (+0.46%)
LLY : 777.66 (+0.62%)
MRNA : 32.54 (+8.83%)
3 Biotech Stocks to Watch: Iovance, Neurocrine & Viking

Timing matters with biotech stocks; these three companies offer distinct risk-reward profiles but have upcoming catalysts that could redefine their value

VKTX : 30.19 (+9.74%)
IOVA : 1.7700 (+4.12%)
NVO : 69.64 (+0.46%)
NBIX : 128.74 (+0.67%)
LLY : 777.66 (+0.62%)
Why This Weight Loss Drug Company's Stock Surged Today

VKTX : 30.19 (+9.74%)
3 Growth Stocks I'm Loading Up On

VKTX : 30.19 (+9.74%)
APLD : 9.22 (-4.55%)
PLTR : 139.71 (+0.42%)
My 5 Favorite Dirt Cheap Stocks to Buy Right Now

TGT : 102.01 (+0.40%)
GOOG : 175.16 (-1.35%)
GOOGL : 174.36 (-1.37%)
VKTX : 30.19 (+9.74%)
CUK : 26.34 (-1.61%)
CCL : 28.84 (-1.60%)
PFE : 25.62 (+1.51%)
2 Biotech Stocks to Buy Before They Soar 84% and 240%, According to Certain Wall Street Analysts

VKTX : 30.19 (+9.74%)
CRSP : 54.82 (+7.09%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Viking Therapeutics, Inc. is a biopharmaceutical company. The company is engaged in development of novel therapies for metabolic and endocrine disorders. Its product candidate consists of VK5211, VK0214, VK0612 and VK2809 which are in different clinical trial. Viking Therapeutics, Inc. is based in LA...

See More

Key Turning Points

3rd Resistance Point 34.51
2nd Resistance Point 32.63
1st Resistance Point 31.41
Last Price 30.19
1st Support Level 28.31
2nd Support Level 26.43
3rd Support Level 25.21

See More

52-Week High 81.73
Fibonacci 61.8% 57.74
Fibonacci 50% 50.32
Fibonacci 38.2% 42.91
Last Price 30.19
52-Week Low 18.92

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar